The decision in a suit challenging a takeover is "a nail in the coffin" of so-called disclosure settlements, an expert says.
A judge finds Bill Ackman can be sued for allegedly buying a stake in Allergan based on inside information about a takeover bid by Valeant Pharmaceuticals.
David Murdock and the company's COO deprived shareholders “of their ability to consider the merger on a fully informed basis and potentially vote it down."
